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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A266were allocated into four groups (n¼9 per group): a) control (explants in
DMEM), b) MPA treatment (control for drug), c) inﬂammation (treat-
ment with interleukin-1b (IL-1b)), and d) inﬂammation followed by
inhibition with MPA (IL-1bþMPA). The MPA (10-7uM) was added fol-
lowing 24 hours of equilibration time in the MPA group. The pro-
inﬂammatory cytokine IL-1b (10ng/ml) was added to the culture media
to initiate inﬂammation in the IL-1b group. For the IL-1bþMPA group,
IL-1b was added following the equilibration time and MPA (10-7uM)
was added 24 hours later. All explants were harvested at 48 hours and
snap frozen in liquid nitrogen and later used for mRNA analysis using
real time qPCR. Matrix metalloproteinase (MMP)-1, MMP-3, and
MMP13 were analyzed in the explants. In addition, one set of fat pad
and synovial explants from each limb was tested for cellular viability
using SYTO13 green ﬂuorescent nucleic acid stain (Invitrogen). ANOVA
with Holm-Sidak's post-hoc analysis was used to determine differences
in mRNA expression between groups, using Prism 6 Graph Pad
software.
Results: Prior to being exposed to the experimental conditions, the cells
in explants from the synovium and fat pad were stained to ensure they
were viable (Figure 1). The mRNA expression levels for MMP-3 and
MMP-13 were suppressed in fat pad tissue when treated with MPA
following induction of inﬂammation (p<0.05) (Figure 3). There were
similar trends in synovium tissue for MMP-3 andMMP-13, however not
signiﬁcant potentially due to considerable animal variation (Figure 2).
Interestingly, MMP-1 exhibited a trend in this pattern of mRNA sup-
pression with MPA in both the fat pad and synovium tissue, although
signiﬁcance was not noted (Figure 2A and 3A).
Conclusions: Early intervention with 10-7uM MPA was successful in
blocking inﬂammation and suppressing some degradative proteinases
such as MMP-3 and MMP-13 after induction of inﬂammation in select
tissues of the knee joint. Interestingly, MMP-1mRNA expression did not
showa signiﬁcant repressionwithMPA. More detailed analysis revealed
that high responder animals in the synovium tissue were not the same
as the high responder animals in the fat pad, thus indicating that there
was tissue speciﬁc variation. Different doses of MPA and longer treat-
ment times are essential for future studies.Figure 1. Live (green) and dead (red), respectively, cell staining in fat pad
(A, B) and synovium (C, D) tissue.Figure 2. Analysis of mRNA expression of MMP-1 (A), MMP-3 (B), and
MMP-13 (C) in synovium tissue explants.Figure 3. Analysis of mRNA expression of MMP-1 (A), MMP-3 (B), and
MMP-13 (C) in fat pad tissue explants.
413
MACROPHAGE PHENOTYPE MODULATION TO CONTROL SYNOVIAL
INFLAMMATION
L. Utomo, G.J. van Osch, J.A. Verhaar, Y.M. Bastiaansen-Jenniskens.
Erasmus MC, Rotterdam, Netherlands
Purpose: Macrophages are involved in the development of osteo-
arthritis (OA). Upon receiving cues from their microenvironment they
can polarize towards a pro-inﬂammatory (M1) or anti-inﬂammatory
(M2) phenotype, where the latter can be further divided into an M2a,
M2b or M2c subtype. A potential strategy to control joint inﬂammation
would be modulating the polarization state of macrophage phenotypes.
The aim of this study was to evaluate compounds from various medi-
cation groups that are all described in literature to have inﬂammation
modulatory effects, on human osteoarthritic synovial explants and on
primary macrophages polarized to M1, M2a and M2c.
Methods: End-stage OA synovial explants were obtained from a patient
who underwent total knee replacement (male, 66Y). To simulate acute
inﬂammation, half of the explants were pre-stimulated for 24h with
IFNgþTNFa. Bone morphogenetic protein 7 (BMP-7), Rapamycin (Rapa),
Dexamethasone (Dex) and Pravastatin (Prava) were added in three
doses to the culture medium. The explants were cultured for an addi-
tional 3 days and assessed for IL6, CCL18 and IL1B gene expression.
Primary human monocytes were isolated and pooled from 11 buffy
coats (male donors, 46±16Y) by Ficoll density separation and CD14þ
selection. The monocytes were cultured in monolayer in X-VIVO 15
medium and stimulated for 3 days with IFNgþTNFa to obtain an ‘M1’-
like macrophage phenotype, stimulated with IL-4 to obtain ‘M2a’ and
IL-10 to obtain an ‘M2c’-like subtype. Protein production of IL-6 was
considered as an M1 marker and CCL18 as an M2 marker, both meas-
ured with ELISA. The experiments were conducted three times with
biological triplicates.
Results: In end-stage OA synovium, BMP-7 and Prava increased IL6 and
CCL18 gene expression, whereas Dex reduced IL6. Rapa reduced CCL18,
but only when the synoviumwas stimulated with inﬂammatory factors.
All compounds reduced IL1B, but was increased in stimulated synovium
except when treated with Dex. Since synovium contains various cell
types, including all subtypes of macrophages, the compounds were
cultured on isolated macrophages polarized to M1, M2a and M2c to
further understand the effects of the compounds on macrophage sub-
types. On M1 macrophages, BMP-7 had no effect regarding IL-6 pro-
duction, Rapa and Prava reduced IL-6 and Dex strongly decreased IL-6
production. Rapa and Dex additionally reduced CCL18 production to
some extent. On M2a macrophages, BMP-7 increased CCL18, Rapa
reduced IL-6 and CCL18, whereas Dex increased both IL6 and CCL18
production. Prava had no effect on M2a macrophages. In M2c macro-
phages. BMP-7 increased CCL18 in a dose dependent manner, Rapa
increased IL6 while decreasing CCL18 and Dex increased both IL6 and
CCL18 production.
Conclusions: BMP-7, Rapa, Dex and Prava were all able to modulate the
behavior of monocyte-derivedmacrophages cultured in monolayer. The
modulatory capacity seemed to depend on macrophage phenotype. The
effects of these compounds on synovial explants can be partially
explained by the effects seen on macrophages. The effect of Dex on
synoviumwas also seen in the monolayer cultures, where a suppression
of M1 macrophages was seen without sacriﬁcing M2a macrophages.
BMP-7 tended to stimulate IL-6 and CCL18 which reﬂected the effects
seen in the monolayer cultures. Prava had a subtle modulatory effect in
both the explants and monolayers. Rapa decreased CCL18 in both
stimulated synovium and in isolated macrophage cultures. These
results indicate that compounds can modulate the behavior of synovial
macrophages and thereby inﬂammation in a joint. To elaborate the
actual modulatory effects of these compounds on synovial macro-
phages, in-depth analysis should be conducted to provide more insight
on a potential treatment regimen to modulate macrophage phenotype.
